# SGF29

## Overview
SGF29 is a gene that encodes the protein SAGA complex associated factor 29, which is a critical component of the SAGA (Spt-Ada-Gcn5 acetyltransferase) complex. This protein is characterized by its structural domains, including a coiled-coil domain and tandem Tudor domains, which facilitate its role in transcriptional regulation through histone modification. The tandem Tudor domains of SGF29 are particularly important for recognizing methylated lysine residues, such as H3K4me3, thereby aiding in the recruitment of the SAGA complex to chromatin and promoting histone acetylation at active promoters (Helmlinger2021What; Espinola-Lopez2021The). SGF29 is also involved in liquid-liquid phase separation, forming nuclear condensates that are essential for its function in chromatin binding and transcriptional activation, particularly in the context of cellular aging and immune regulation (Chen2021Conservation; Yan2023SGF29). The gene's expression and function have significant implications in various biological processes and diseases, including cancer and age-related conditions, making it a potential target for therapeutic interventions (Yan2023SGF29; Zhang2022A).

## Structure
SGF29 is a protein characterized by specific structural domains that contribute to its function within the SAGA complex. The protein contains a coiled-coil domain at the N-terminus (amino acids 3-98) and two tandem Tudor domains at the C-terminus (amino acids 160-212 and 232-286) (Yan2023SGF29). These Tudor domains are crucial for SGF29's ability to undergo liquid-liquid phase separation (LLPS), a process important for forming nuclear condensates that play a role in cellular aging (Yan2023SGF29). The tandem Tudor domains are known to recognize methylated lysine residues, such as H3K4me3, which is important for chromatin binding and transcriptional regulation (Espinola-Lopez2021The).

SGF29 also contains four intrinsically disordered regions (IDRs), with the first located at the N-terminus (amino acids 1-53) and the remaining three at the C-terminus (amino acids 54-293) (Yan2023SGF29). These IDRs, particularly the tandem Tudor domains, are flexible and unstructured, which is typical for proteins capable of LLPS (Yan2023SGF29). The protein's ability to form phase-separated condensates is influenced by specific residues, such as arginine at position 207 (R207), which is critical for phase separation and chromatin binding (Yan2023SGF29). Mutations in these residues can significantly affect SGF29's function (Yan2023SGF29).

## Function
SGF29 is a component of the SAGA complex, which plays a crucial role in transcription regulation through histone modification. It is involved in recognizing and binding to methylated histones, specifically H3K4me3, facilitating the recruitment of the SAGA complex to chromatin. This interaction is essential for maintaining acetylation of nucleosomes at active promoters, thereby playing a role in gene expression regulation (Helmlinger2021What; Espinola-Lopez2021The).

SGF29 contains a double Tudor domain that is crucial for its function. This domain binds to tri-methylated histone H3K4, which is a marker of active promoters, and facilitates the recruitment of the histone acetyltransferase (HAT) module to chromatin (Helmlinger2021What). The interaction between SGF29 and H3K4me3 enhances histone acetylation, correlating H3 acetylation with H3K4 methylation, and explains the SAGA complex's activity at promoters enriched for H3K4me3 (Espinola-Lopez2021The).

In healthy human cells, SGF29 is highly expressed in skeletal muscle and blood cells, including T cells, suggesting its involvement in muscle differentiation and immune regulation (Chen2021Conservation). Its expression pattern aligns with its role as a positive modulator of forkhead box P3 (FOXP3) expression in regulatory T cells (Tregs) (Chen2021Conservation).

## Clinical Significance
Mutations and alterations in the expression of the SGF29 gene have significant clinical implications, particularly in the context of cellular aging and cancer. SGF29 is involved in the formation of nuclear condensates through liquid-liquid phase separation, which is crucial for the transcriptional activation of senescence-associated genes. Mutations such as SGF29-R207P and SGF29-D194A impair its ability to bind chromatin and activate genes like CDKN1A, which encodes the senescence marker protein p21 Cip1. This disruption can lead to a failure to induce cellular senescence, potentially contributing to age-related diseases (Yan2023SGF29).

In cancer, SGF29 has been implicated in the regulation of proto-oncogene MYC and is essential for the malignant transformation of hepatocellular carcinoma and acute myeloid leukemia. Alterations in SGF29 expression or its interactions could contribute to these malignancies (Yan2023SGF29). Additionally, SGF29 is part of a risk score model for predicting survival in lower-grade gliomas, where its expression is associated with better prognosis. Changes in SGF29 expression may influence immune cell infiltration in tumors, affecting clinical outcomes (Zhang2022A). These findings underscore the potential of SGF29 as a target for therapeutic interventions in age-related and cancerous conditions.

## Interactions
SGF29 is a component of the SAGA complex, where it plays a crucial role in transcription regulation through its interactions with other proteins and nucleic acids. Within the SAGA complex, SGF29 interacts with proteins such as Ada3, Gcn5, and other ADA family members, forming part of the histone acetyltransferase (HAT) module. This interaction is essential for the acetylation of histone H3, particularly in the presence of the H3K4me3 modification, which SGF29 recognizes through its tandem Tudor domains (Ringel2015Nucleosome; Lee2011Combinatorial; Espinola-Lopez2021The).

SGF29 also forms liquid-like nuclear condensates through phase separation, a process that is enhanced by RNA and is crucial for its function in chromatin binding and transcriptional activation. The Arg 207 residue in SGF29 is vital for this phase separation, and mutations at this site can disrupt its ability to form condensates and bind chromatin (Yan2023SGF29).

In the context of cellular aging, SGF29 interacts with transcriptional partners such as MED4 and SP1, colocalizing at the CDKN1A promoter to promote the expression of senescence-associated genes. These interactions are dependent on SGF29's ability to undergo phase separation, highlighting its role in transcriptional regulation and cellular senescence (Yan2023SGF29).


## References


[1. (Lee2011Combinatorial) Kenneth K Lee, Mihaela E Sardiu, Selene K Swanson, Joshua M Gilmore, Michael Torok, Patrick A Grant, Laurence Florens, Jerry L Workman, and Michael P Washburn. Combinatorial depletion analysis to assemble the network architecture of the saga and ada chromatin remodeling complexes. Molecular Systems Biology, January 2011. URL: http://dx.doi.org/10.1038/msb.2011.40, doi:10.1038/msb.2011.40. This article has 138 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/msb.2011.40)

[2. (Ringel2015Nucleosome) Alison E. Ringel, Anne M. Cieniewicz, Sean D. Taverna, and Cynthia Wolberger. Nucleosome competition reveals processive acetylation by the saga hat module. Proceedings of the National Academy of Sciences, September 2015. URL: http://dx.doi.org/10.1073/pnas.1508449112, doi:10.1073/pnas.1508449112. This article has 55 citations.](https://doi.org/10.1073/pnas.1508449112)

[3. (Yan2023SGF29) Kaowen Yan, Qianzhao Ji, Dongxin Zhao, Mingheng Li, Xiaoyan Sun, Zehua Wang, Xiaoqian Liu, Zunpeng Liu, Hongyu Li, Yingjie Ding, Si Wang, Juan Carlos Izpisua Belmonte, Jing Qu, Weiqi Zhang, and Guang-Hui Liu. Sgf29 nuclear condensates reinforce cellular aging. Cell Discovery, November 2023. URL: http://dx.doi.org/10.1038/s41421-023-00602-7, doi:10.1038/s41421-023-00602-7. This article has 5 citations.](https://doi.org/10.1038/s41421-023-00602-7)

[4. (Chen2021Conservation) Ying-Jiun C. Chen and Sharon Y. R. Dent. Conservation and diversity of the eukaryotic saga coactivator complex across kingdoms. Epigenetics &amp; Chromatin, June 2021. URL: http://dx.doi.org/10.1186/s13072-021-00402-x, doi:10.1186/s13072-021-00402-x. This article has 19 citations.](https://doi.org/10.1186/s13072-021-00402-x)

[5. (Espinola-Lopez2021The) Jose M. Espinola-Lopez and Song Tan. The ada2/ada3/gcn5/sgf29 histone acetyltransferase module. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1864(2):194629, February 2021. URL: http://dx.doi.org/10.1016/j.bbagrm.2020.194629, doi:10.1016/j.bbagrm.2020.194629. This article has 26 citations.](https://doi.org/10.1016/j.bbagrm.2020.194629)

[6. (Helmlinger2021What) Dominique Helmlinger, Gábor Papai, Didier Devys, and László Tora. What do the structures of gcn5-containing complexes teach us about their function? Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1864(2):194614, February 2021. URL: http://dx.doi.org/10.1016/j.bbagrm.2020.194614, doi:10.1016/j.bbagrm.2020.194614. This article has 24 citations.](https://doi.org/10.1016/j.bbagrm.2020.194614)

[7. (Zhang2022A) Yongfeng Zhang, Beibei Yu, Yunze Tian, Pengyu Ren, Boqiang Lyu, Longhui Fu, Huangtao Chen, Jianzhong Li, and Shouping Gong. A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas. Frontiers in Genetics, September 2022. URL: http://dx.doi.org/10.3389/fgene.2022.957059, doi:10.3389/fgene.2022.957059. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.957059)